A study to assess the long-term safety and efficacy of dupilumab administered in patients 6 to <18 year of age with atopic dermatitis (eczema)

Update Il y a 4 ans
Reference: EUCTR2015-001396-40

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric patients with AD.


Inclusion criteria

  • Atopic dermatitis